CIMB Reiterates Outperform Rating for Sonic Healthcare Limited (SHL)
Sonic Healthcare Limited (ASX:SHL)‘s stock had its “outperform” rating reaffirmed by equities research analysts at CIMB in a research note issued to investors on Monday, AnalystRatingsNetwork.com reports. They currently have a $16.91 target price on the stock, up from their previous target price of $16.76.
Shares of Sonic Healthcare Limited (ASX:SHL) traded down 1.38% on Monday, hitting A$15.670. 732,747 shares of the company’s stock traded hands. Sonic Healthcare Limited has a 1-year low of A$12.330 and a 1-year high of A$15.300. The stock has a 50-day moving average of A$15.06 and a 200-day moving average of A$14.22. The company has a market cap of A$6.223 billion and a price-to-earnings ratio of 18.85.
Sonic Healthcare Limited is engaged in the provision of medical diagnostic services and the provision of administrative services and facilities to medical practitioners.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.